Prognostic Implications of Physiologic Investigation After Revascularization With Stent
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
Summary
- Conditions
- Coronary Disease
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Retrospective
Participation Requirements
- Age
- Between 20 years and 100 years
- Gender
- Both males and females
Description
This study population was incorporated from studies which were already published. Investigators will incorporate all known registries to the POST-PCI FLOW registry by requesting data from principal investigator of each registry. Investigators will perform systemic review of the previous published da...
This study population was incorporated from studies which were already published. Investigators will incorporate all known registries to the POST-PCI FLOW registry by requesting data from principal investigator of each registry. Investigators will perform systemic review of the previous published data and an updated patient-level meta-analysis of studies, including the most recent publications. PubMed, EMBASE, Cochrane Central Register of Controlled Trials, the United States National Institutes of Health registry of clinical trials, and relevant websites were searched for pertinent published studies. The electronic search strategy was complemented by manual examination of references cited by included articles, recent reviews, editorials, and meta-analyses. No restrictions were imposed on language, study period, or sample size. Searching key words included 'post', 'after', 'PCI', 'Percutaneous coronary intervention', 'coronary stenting', 'stenting', 'stent', 'stent implantation', 'FFR', and 'fractional flow reserve'.
Tracking Information
- NCT #
- NCT04684043
- Collaborators
- Nagoya City University Graduate School of Medical Science, Nagoya, Japan
- Inje University Ilsan Paik Hospital, Goyang, South Korea
- Nanjing First Hospital, Nanjing Medical University, Nanjing, China
- Tsuchiura Kyodo General Hospital
- McGovern Medical School at UTHealth and Memorial Hermann Hospital, TX, USA
- Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
- Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- San Raffaele Scientific Institute, Milan, Italy
- Ajou University Hospital, Suwon, South Korea
- University of Cincinnati
- Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
- Kyoto Second Red Cross Hospital, Kyoto, Japan
- Investigators
- Study Chair: Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, South Korea Principal Investigator: Joon Hyung MD, PhD, MD, PhD Inje University Ilsan Paik Hospital, Goyang, South Korea Principal Investigator: Shao-Liang Chen, MD Nanjing First Hospital, Nanjing Medical University, Nanjing, China Principal Investigator: Tsunekazu Kakuta, MD, PhD Tsuchiura Kyodo General Hospital Principal Investigator: Nils P. Johnson, MD, MS McGovern Medical School at UTHealth and Memorial Hermann Hospital, TX, USA Principal Investigator: Tsuyoshi Ito, MD Nagoya City University Graduate School of Medical Science, Nagoya, Japan Principal Investigator: Abdul Hakeem, MD Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey Principal Investigator: Bernard De Bruyne, MD, PhD Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium Principal Investigator: Lorenzo Azzalini, MD, PhD San Raffaele Scientific Institute, Milan, Italy Principal Investigator: Hong-Seok Lim, MD, PhD Ajou University Hospital, Suwon, South Korea Principal Investigator: Massoud A. Leesar, MD, PhD, MSc University of Cincinnati Principal Investigator: Akiko Matsuo, MD Kyoto Second Red Cross Hospital, Kyoto, Japan Principal Investigator: Nobuhiro Tanaka, MD, PhD, MSc Tokyo Medical University Hachioji Medical Center, Tokyo, Japan Principal Investigator: Joo Myung Lee, MD, PhD, MSc Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Get Well Soon